--- title: "PMA Supplement Types, Definition | MedTech Terms" description: "FDA's five-way taxonomy for post-approval PMA changes, Panel-Track, 180-Day, Real-Time, Special, and 30-Day Notice, each with distinct content and timing." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/pma-supplement-types#term", "name": "PMA Supplement Types", "description": "After PMA approval, manufacturers must submit a PMA Supplement for most changes to the device, manufacturing, or labeling. FDA recognizes five supplement types: (1) Panel-Track Supplement for significant changes affecting safety or effectiveness, with a new clinical or expert panel review; (2) 180-Day Supplement for major changes evaluated within a 180-day review goal; (3) Real-Time Supplement for minor changes reviewed in a scheduled meeting; (4) Special PMA Supplement (Changes Being Effected) for specific manufacturing or labeling changes that can be implemented while FDA reviews; (5) 30-Day Notice for manufacturing process changes meeting predefined criteria.", "url": "https://medtechterms.com/terms/pma-supplement-types", "termCode": "pma-supplement-types", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/pma-supplement-types#article", "headline": "PMA Supplement Types", "description": "FDA's five-way taxonomy for post-approval PMA changes, Panel-Track, 180-Day, Real-Time, Special, and 30-Day Notice, each with distinct content and timing.", "url": "https://medtechterms.com/terms/pma-supplement-types", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/pma-supplement-types" }, "about": { "@id": "https://medtechterms.com/terms/pma-supplement-types#term" }, "articleSection": "Regulatory", "inLanguage": "en", "keywords": "PMA Supplement Types, Regulatory, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-06-20", "dateModified": "2026-06-20", "citation": [ { "@type": "CreativeWork", "name": "21 CFR 814.39 - PMA Supplements", "url": "https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-814/subpart-B/section-814.39", "publisher": { "@type": "Organization", "name": "eCFR" } }, { "@type": "CreativeWork", "name": "Modifications to Devices Subject to PMA Guidance", "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/modifications-devices-subject-premarket-approval-pma-pma-supplement-decision-making-process", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "IMDRF Documents", "url": "https://www.imdrf.org/documents", "publisher": { "@type": "Organization", "name": "IMDRF" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/pma#term", "name": "Premarket Approval", "alternateName": "PMA", "url": "https://medtechterms.com/terms/pma" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/pma-modular#term", "name": "Modular PMA", "url": "https://medtechterms.com/terms/pma-modular" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/pma-real-time-review#term", "name": "Real-Time PMA Supplement Review", "url": "https://medtechterms.com/terms/pma-real-time-review" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/annual-report-pma#term", "name": "Annual Report (PMA)", "url": "https://medtechterms.com/terms/annual-report-pma" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/change-control#term", "name": "Change Control", "url": "https://medtechterms.com/terms/change-control" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/ai-ml-pccp#term", "name": "Predetermined Change Control Plan", "alternateName": "PCCP", "url": "https://medtechterms.com/terms/ai-ml-pccp" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Regulatory", "item": "https://medtechterms.com/terms?cat=Regulatory" }, { "@type": "ListItem", "position": 4, "name": "PMA Supplement Types", "item": "https://medtechterms.com/terms/pma-supplement-types" } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Regulatory](/terms?cat=Regulatory) 6. / 7. PMA Supplement Types [All terms](/terms) Regulatory [Regulated Pathways](/ecosystems/regulated-pathways)[Global Markets](/ecosystems/global-markets) # PMA Supplement Types FDA's five-way taxonomy for post-approval PMA changes, Panel-Track, 180-Day, Real-Time, Special, and 30-Day Notice, each with distinct content and timing. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed June 20, 2026 ## Definition After [PMA](/terms/pma) approval, manufacturers must submit a PMA Supplement for most changes to the device, manufacturing, or [labeling](/terms/labeling). FDA recognizes five supplement types: (1) Panel-Track Supplement for significant changes affecting safety or effectiveness, with a new clinical or expert panel review; (2) 180-Day Supplement for major changes evaluated within a 180-day review goal; (3) Real-Time Supplement for minor changes reviewed in a scheduled meeting; (4) Special PMA Supplement (Changes Being Effected) for specific manufacturing or labeling changes that can be implemented while FDA reviews; (5) 30-Day Notice for manufacturing process changes meeting predefined criteria. What the regulation says 21 CFR 814.39 governs [PMA](/terms/pma) supplements. FDA's 'Modifications to Devices Subject to Premarket Approval' guidance walks through supplement-type selection logic. ## What this means in practice Choosing the right supplement type is one of the highest-leverage regulatory decisions for a [PMA](/terms/pma) device. A Panel-Track supplement may take 12-18 months; a 30-Day Notice clears in 30 days if criteria are met. The 30-Day Notice pathway in particular is powerful for manufacturing optimization but is gated by very specific eligibility criteria. The annual PMA report (separate from supplements) covers minor changes that don't require any supplement. Common pitfalls - • Defaulting to a 180-Day Supplement when a 30-Day Notice would suffice, wastes 5 months unnecessarily. - • Treating Special PMA Supplements (CBE) as universally applicable, they are restricted to specific change types defined in 21 CFR 814.39(d). - • Letting changes accumulate into an annual report when individually they crossed the supplement threshold. ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Regulatory Modular PMA PMA submission strategy where a manufacturer submits portions of the PMA (modules) sequentially as they become ready, rather than as a single complete application. ](/terms/pma-modular)[ Regulatory Premarket Approval(PMA) FDA's most stringent device marketing application, required for high-risk Class III devices. ](/terms/pma)[ Regulatory Real-Time PMA Supplement Review Expedited PMA supplement review pathway where FDA and the manufacturer meet to review minor device or labeling changes in real time. ](/terms/pma-real-time-review)[ Post-Market Annual Report (PMA) Yearly report required for Class III PMA devices summarizing changes, complaints, and post-approval study status. ](/terms/annual-report-pma) ### More in Regulatory · Same category [ Regulatory 510(k) Premarket Notification(510(k)) FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate. ](/terms/510k)[ Regulatory 510(k) Summary vs 510(k) Statement Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request. ](/terms/510k-summary-vs-statement)[ Regulatory 513(g) Request for Information(513(g)) Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification. ](/terms/513g)[ Regulatory Abbreviated 510(k) 510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards. ](/terms/abbreviated-510k) Cited by Where this term appears across MedTech Terms. Ecosystems (2) - [Regulated Pathways](/ecosystems/regulated-pathways) - [Global Markets](/ecosystems/global-markets) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 eCFR· 1 FDA· 1 IMDRF· 1 1. [1 21 CFR 814.39 - PMA Supplements Verified eCFR · ecfr.gov ](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-814/subpart-B/section-814.39) 2. [2 Modifications to Devices Subject to PMA Guidance Verified FDA · fda.gov ](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/modifications-devices-subject-premarket-approval-pma-pma-supplement-decision-making-process) 3. [3 IMDRF Documents Verified IMDRF · imdrf.org ](https://www.imdrf.org/documents) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Navigating an FDA or EU MDR submission? Blue Goat Cyber supports the cybersecurity content of premarket submissions, from threat models to the 524B narrative. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Regulatory Sources 3 Updated 6/20/2026 [Compare with another term](/compare?a=pma-supplement-types) Learn in 60 seconds Card Lesson Quiz FDA's five-way taxonomy for post-approval PMA changes, Panel-Track, 180-Day, Real-Time, Special, and 30-Day Notice, each with distinct content and timing. - · Choosing the right supplement type is one of the highest-leverage regulatory decisions for a PMA device. - · A Panel-Track supplement may take 12-18 months; a 30-Day Notice clears in 30 days if criteria are met. - · The 30-Day Notice pathway in particular is powerful for manufacturing optimization but is gated by very specific eligibility criteria. Remember this Watch out: Defaulting to a 180-Day Supplement when a 30-Day Notice would suffice, wastes 5 months unnecessarily. Related terms - [Premarket Approval(PMA) ](/terms/pma) - [Modular PMA ](/terms/pma-modular) - [Real-Time PMA Supplement Review ](/terms/pma-real-time-review) - [Annual Report (PMA) ](/terms/annual-report-pma) - [Change Control ](/terms/change-control) - [Predetermined Change Control Plan(PCCP) ](/terms/ai-ml-pccp) You may also need Auto-suggested from Regulatory and shared keywords. - [510(k) Summary vs 510(k) Statement ](/terms/510k-summary-vs-statement) - [NMPA Innovative Medical Device Pathway ](/terms/nmpa-innovation) - [Notified Body Scrutiny (IVDR Class D) ](/terms/ivdr-notified-body-scrutiny) - [De Novo Classification Request(De Novo) ](/terms/de-novo) - [Common Specifications (IVDR)(CS) ](/terms/ivdr-common-specifications) - [Emergency Use Authorization(EUA) ](/terms/eua) [All Regulatory terms](/terms?cat=Regulatory) From the Blue Goat network Related resources and services on this topic. - [ MedTech Cybersecurity Standards Authoritative reference for the standards and guidances behind medical device cybersecurity. ](https://medtechcyberstandards.com) - [ MedTech Cybersecurity Crosswalk International crosswalk of medical device cybersecurity requirements across regulators. ](https://mdccrosswalk.com) - [ MedTech Truths Common misconceptions about medical device development - debunked. ](https://mdcmisconceptions.com) - [ MedTech Launchpad MedTech funding rounds, accelerators, and launch resources. ](https://medtechlaunchguide.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)